SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kimia Biosciences - Quaterly Results

20 Aug 2024 Evaluate
The sales for the June 2024 quarter moved down to Rs. 223.99 millions as compared to Rs. 242.30 millions during the year-ago period.The Total Profit for the quarter ended June 2024 of Rs. 14.38 millions grew from Rs.-27.11 millions Operating profit Margin for the quarter ended June 2024 improved to 37.89% as compared to -15.14% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 223.99 242.30 -7.56 223.99 242.30 -7.56 1048.77 1285.16 -18.39
Other Income 0.83 1.25 -33.60 0.83 1.25 -33.60 16.42 12.13 35.37
PBIDT 37.89 -15.14 -350.26 37.89 -15.14 -350.26 11.59 -37.63 -130.80
Interest 11.08 12.76 -13.17 11.08 12.76 -13.17 50.50 42.45 18.96
PBDT 26.81 -27.90 -196.09 26.81 -27.90 -196.09 -38.91 -90.56 -57.03
Depreciation 8.98 8.32 7.93 8.98 8.32 7.93 32.92 33.32 -1.20
PBT 17.83 -36.22 -149.23 17.83 -36.22 -149.23 -71.83 -123.88 -42.02
TAX 3.45 -9.11 -137.87 3.45 -9.11 -137.87 -18.75 -30.36 -38.24
Deferred Tax 0.48 -9.11 -105.27 0.48 -9.11 -105.27 -18.75 -30.36 -38.24
PAT 14.38 -27.11 -153.04 14.38 -27.11 -153.04 -53.08 -93.52 -43.24
Equity 47.31 47.31 0.00 47.31 47.31 0.00 47.31 47.31 0.00
PBIDTM(%) 16.92 -6.25 -370.72 16.92 -6.25 -370.72 1.11 -2.93 -137.74

Kimia Biosciences Share Price

37.68 0.24 (0.64%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×